• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Identifying coronary artery bypass grafting patients at high risk for adverse long-term prognosis using serial health-related quality of life assessments
CONCLUSIONS: Baseline MCS and changes in MCS were independent predictors for long-term mortality of CABG. Better mental health status and recovery indicated better prognosis.PMID:37620281 | DOI:10.1097/CM9.0000000000002806
Source: Chinese Medical Journal - August 24, 2023 Category: General Medicine Authors: Juncheng Wang Hanning Liu Chao Yue Limeng Yang Kai Yang Yan Zhao Huan Ren Ying Zhang Zhe Zheng Source Type: research

Implications of left atrial volume index in patients with three-vessel coronary disease: A 6.6-year follow-up cohort study
CONCLUSIONS: LAVI is a potential index for risk stratification and therapeutic decision-making in patients with three-vessel coronary disease. CABG is associated with improved long-term outcomes compared with MT alone, regardless of LAVI quartiles. When LAVI is severely elevated, PCI is associated with higher risk of cardiac death than CABG.PMID:37262047 | DOI:10.1097/CM9.0000000000002723
Source: Chinese Medical Journal - June 1, 2023 Category: General Medicine Authors: Ru Liu Lei Song Ce Zhang Lin Jiang Jian Tian Lianjun Xu Xinxing Feng Linyuan Wan Xueyan Zhao Ou Xu Chongjian Li Runlin Gao Rutai Hui Wei Zhao Jinqing Yuan Source Type: research

Atorvastatin and the influence on postoperative atrial fibrillation after surgical aortic valve replacement (STARC) in adults at Odense University Hospital, Denmark: study protocol for a randomised controlled trial
Introduction Atrial fibrillation (AF) is the most common postoperative complication after surgical aortic valve replacement (SAVR) and occurs in up to 50% of the patients. Development of postoperative AF (POAF) is associated with a 2–3 fold increased risk of adverse events, including stroke, myocardial infarction and death. Several studies have implied that prophylactic Atorvastatin therapy could prevent POAF in patients undergoing coronary artery bypass graft. These studies suggest that Atorvastatin has rapid and significant pleiotropic actions that reduce the risk of POAF. However, prophylactic treatment with stati...
Source: BMJ Open - May 10, 2023 Category: General Medicine Authors: Krasniqi, L., Brandes, A., Mortensen, P. E., Dahl, J. S., Gerke, O., Ali, M., Riber, L. P. S. Tags: Open access, Cardiovascular medicine Source Type: research

Outcome differences between surgeons performing first and subsequent coronary artery bypass grafting procedures in a day: a retrospective comparative cohort study
Conclusions For a technically challenging surgical procedure like off-pump CABG, prior workload adversely affected patient outcomes.
Source: BMJ Quality and Safety - March 17, 2023 Category: General Medicine Authors: Zhang, D., Gu, D., Rao, C., Zhang, H., Su, X., Chen, S., Ma, H., Zhao, Y., Feng, W., Sun, H., Zheng, Z. Tags: Editor's choice Original research Source Type: research

Revascularisation and outcomes after acute coronary syndromes in patients with prior coronary artery bypass grafting-ANZACS-QI 67
CONCLUSION: In contemporary real-world practice, despite half of the patients with ACS and prior CABG receiving PCI, the outcomes remain poor compared with those without prior CABG.PMID:36201732
Source: New Zealand Medical Journal - October 6, 2022 Category: General Medicine Authors: Danting Wei Jithendra B Somaratne Mildred Lee Andrew Kerr Source Type: research

Pages: 1  2  3  4  5  6  7